Search Results - "Konde, Anish S"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A comparative study of brainstem auditory evoked potentials in preterm and full-term infants by Roopakala, M S, Dayananda, G, Manjula, P, Konde, Anish S, Acharya, P T, Srinivasa, R, Nirmala, K S

    “…Preterm infants can have many neurological problems. An enormous amount of fetal brain development occurs during the last trimester of pregnancy. They include…”
    Get more information
    Journal Article
  2. 2

    ATM mutation carriers and family history of pancreatic cancer by Klavanian, Jeannie, Zakalik, Dana, Konde, Anish S, Rangarajan, Tara

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only 1529 Background: Multigene panel testing (MGT) is commonly utilized in patients with a personal or family history of cancer. One of the more…”
    Get full text
    Journal Article
  3. 3

    Heterozygous germline ATM mutations in breast cancer: A single academic center experience by Konde, Anish S, Ivan, Kristina, Klavanian, Jeannie, Rangarajan, Tara, Jaiyesimi, Ishmael A., Zakalik, Dana

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only 1537 Background: Heterozygous germline ATM mutation carriers have an increased risk of developing breast, pancreas, and other cancers. The…”
    Get full text
    Journal Article
  4. 4

    Outcomes in Heparin-Induced Thrombocytopenia Managed with Direct Oral Anticoagulants by Anusim, Nwabundo, Ionescu, Filip, Konde, Anish S, Jindal, Vishal, Gupta, Ruby, Huben, Marianne Terese, Gaikazian, Susanna, Jaiyesimi, Ishmael

    Published in Blood (13-11-2019)
    “…Background: Heparin-induced thrombocytopenia (HIT) occurs as a result of autoantibodies to the platelet factor 4 (PF4)-heparin complex, which activate the…”
    Get full text
    Journal Article
  5. 5

    Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients by Ionescu, Filip, Nair, Girish B, Petrescu, Ioana, Konde, Anish S, Zimmer, Markie Sue, Anusim, Nwabundo, Jindal, Vishal, Gaikazian, Susanna, Anderson, Joseph, Stender, Michael, Huben, Marianne Terese, Jaiyesimi, Ishmael

    Published in Blood (05-11-2020)
    “…▪ Background: Hypercoagulability may contribute to COVID-19 pathogenicity. Evidence comparing clinical outcomes among patients with COVID-19 receiving…”
    Get full text
    Journal Article
  6. 6

    Clinical Outcome Following Reinstitution of Anticoagulation after Major Gastrointestinal Bleed: A Single Institutional Analysis by Ezekwudo, Daniel E, Gaikazian, Susanna, Anusim, Nwabundo, Konde, Anish S, Zakalik, Dana, Huben, Marianne Terese, Stender, Michael, Anderson, Joseph, Jaiyesimi, Ishmael

    Published in Blood (29-11-2018)
    “…Introduction: Arterial and venous thromboembolic events, including stroke and myocardial infarction, are a leading cause of morbidity and mortality in the…”
    Get full text
    Journal Article
  7. 7

    Outcome of Lymphocyte Predominant Hodgkin Lymphoma: A Single Institutional Analysis by Ezekwudo, Daniel E, Anusim, Nwabundo, Konde, Anish S, Gbadamosi, Bolanle, Khoury, John, Macari, David, Zakalik, Dana, Blankenship, Leann, Gaikazian, Susanna, Jaiyesimi, Ishmael

    Published in Blood (29-11-2018)
    “…Background: Nearly 5% of patients diagnosed with Hodgkin lymphoma have the nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), also known as Hodgkin…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Neighborhood Death Rate: A Big-Data Based Health Informatics Pipeline Helps Identify Factors Impacting Clinical Outcomes and Cost Effectiveness in Acute Myeloid Leukemia Patients by Yin, Zheng, Konde, Anish S, Puppala, Mamta, Srivastava, Pallavi, Stephen, Wong, Rice, Lawrence, Padmanabhan Iyer, Swaminathan

    Published in Blood (06-12-2014)
    “…Background Acute Myeloid Leukemia (AML) affects 18,860 adults in the US and is expected to account for 10,460 deaths of all mortalities due to leukemia…”
    Get full text
    Journal Article
  10. 10

    A Retrospective Review Of Factor X Levels and Bleeding Risk In Patients With Amyloidosis by Konde, Anish S., Camposano, Charles, Farah, Mushtaq, Mamta, Puppala, Solomon, Wong, Carrum, George, John, McCarthy, Baker, Kelty R., Estep, Jerry, Bhimraj, Arvind, Kamble, Rammurti, Rice, Lawrence, Iyer, Swaminathan Padmanabhan

    Published in Blood (15-11-2013)
    “…Bleeding is a common presentation of light chain AL amyloidosis mainly attributable to vascular fragility and impaired vasoconstriction also known as Amyloid…”
    Get full text
    Journal Article